These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 16648153)

  • 1. The significance of premature luteinization in an oocyte-donation programme.
    Melo MA; Meseguer M; Garrido N; Bosch E; Pellicer A; Remohí J
    Hum Reprod; 2006 Jun; 21(6):1503-7. PubMed ID: 16648153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of pregnancy outcomes in anonymous shared versus exclusive donor oocyte in vitro fertilization cycles.
    Mullin CM; Fino ME; Talebian S; Keegan D; Grifo JA; Licciardi F
    Fertil Steril; 2010 Feb; 93(2):574-8. PubMed ID: 19815192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An increased serum progesterone-to-estradiol ratio on the day of human chorionic gonadotropin administration does not have a negative impact on clinical pregnancy rate in women with normal ovarian reserve treated with a long gonadotropin releasing hormone agonist protocol.
    Lai TH; Lee FK; Lin TK; Horng SG; Chen SC; Chen YH; Wang PC
    Fertil Steril; 2009 Aug; 92(2):508-14. PubMed ID: 18701101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premature luteinization and in vitro fertilization outcome in gonadotropin/gonadotropin-releasing hormone antagonist cycles in women with polycystic ovary syndrome.
    Segal S; Glatstein I; McShane P; Hotamisligil S; Ezcurra D; Carson R
    Fertil Steril; 2009 May; 91(5):1755-9. PubMed ID: 18394616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized study.
    Escribá MJ; Bellver J; Bosch E; Sánchez M; Pellicer A; Remohí J
    Fertil Steril; 2006 Jul; 86(1):92-7. PubMed ID: 16818032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical effects of oocyte cryopreservation in assisted reproduction technology].
    Wang W; Yan ZJ; Cai LB; Chai DC; Liu CZ; Mao YD; Liu JY
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(39):2755-8. PubMed ID: 19080449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of GnRH antagonists and flareup GnRH agonists in donor oocyte cycles.
    Wei AY; Mijal KA; Christianson MS; Schouweiler CM; Lindheim SR
    J Reprod Med; 2008 Mar; 53(3):147-50. PubMed ID: 18441715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience employing co-culture of human embryos with autologous human endometrial epithelial cells.
    Rubio C; Simón C; Mercader A; Garcia-Velasco J; Remohí J; Pellicer A
    Hum Reprod; 2000 Dec; 15 Suppl 6():31-8. PubMed ID: 11261481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of oocyte vitrification combined with blastocyst stage transfer in an egg donation program.
    García JI; Noriega-Portella L; Noriega-Hoces L
    Hum Reprod; 2011 Apr; 26(4):782-90. PubMed ID: 21303777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality.
    Hofmann GE; Bentzien F; Bergh PA; Garrisi GJ; Williams MC; Guzman I; Navot D
    Fertil Steril; 1993 Oct; 60(4):675-9. PubMed ID: 8405524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryo cryopreservation rescues cycles with premature luteinization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Hudson C; Thomas S
    Fertil Steril; 2010 Feb; 93(2):636-41. PubMed ID: 19296941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation.
    Styne-Gross A; Elkind-Hirsch K; Scott RT
    Fertil Steril; 2005 Jun; 83(6):1629-34. PubMed ID: 15950629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting patterns in in vitro fertilization pregnancy rates among fresh autologous, fresh oocyte donor, and cryopreserved cycles with the use of day 5 or day 6 blastocysts may reflect differences in embryo-endometrium synchrony.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R
    Fertil Steril; 2008 Jan; 89(1):20-6. PubMed ID: 17224151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended induction of ovulation by human menopausal gonadotropins and a gonadotropin-releasing hormone analog in high responders for in vitro fertilization and oocyte donation.
    Amit A; Yaron Y; Azem F; Peyser MR; David MP; Lessing JB
    J Reprod Med; 1995 Sep; 40(9):633-7. PubMed ID: 8576879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of factors associated with multiple pregnancy in an oocyte donation programme.
    Clua E; Tur R; Coroleu B; Boada M; Barri PN; Veiga A
    Reprod Biomed Online; 2010 Nov; 21(5):694-9. PubMed ID: 20880746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryopreserved blastocyst transfer: impact of gonadotropin-releasing hormone agonist versus antagonist in the previous oocyte retrieval cycles.
    Lee JR; Choi YS; Jee BC; Ku SY; Suh CS; Kim KC; Lee WD; Kim SH
    Fertil Steril; 2007 Nov; 88(5):1344-9. PubMed ID: 17548083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R
    Fertil Steril; 2007 Jul; 88(1):237-9. PubMed ID: 17296193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blastocyst embryo transfer is the primary determinant for improved outcomes in oocyte donation cycles.
    Porat N; Boehnlein LM; Barker MA; Kovacs P; Lindheim SR
    J Obstet Gynaecol Res; 2010 Apr; 36(2):357-63. PubMed ID: 20492388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar ongoing pregnancy rates after blastocyst transfer in fresh donor cycles and autologous cycles using cryopreserved bipronuclear oocytes suggest similar viability of transferred blastocysts.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Hudson C; Thomas S
    Fertil Steril; 2010 Jan; 93(1):319-21. PubMed ID: 19683230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormonal therapy for the synchronization between donor and recipient in an oocyte donation and surrogacy fertilization in vitro-embryo transfer program].
    Zhang L; Chen G; Liu P
    Zhonghua Fu Chan Ke Za Zhi; 1996 Aug; 31(8):486-9. PubMed ID: 9275443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.